Franklin S R, Baker L E, Svensson K A
CNS Diseases Research, Pharmacia & Upjohn, Inc., Kalamazoo, MI 49001, USA.
Psychopharmacology (Berl). 1998 Jul;138(1):40-6. doi: 10.1007/s002130050643.
It was recently documented that the relatively selective dopamine D3 receptor antagonist, PNU-99194A, is capable of establishing discriminative stimulus control in rats and that the discriminative cue associated with this compound is not similar to that produced by psychostimulants. The present experiment further characterized the discriminative stimulus properties of PNU-99194A by examining several other dopaminergic agents for stimulus generalization in 23 male Sprague-Dawley rats trained to discriminate 10 mg/kg PNU-99194A (SC, 15 min) from vehicle in a two-choice discrimination procedure under an FR10 schedule of food reinforcement. Rats achieved a criterion of ten consecutive sessions with correct lever choice after a median of 35.5 sessions (range 23-78). In substitution tests, the non-selective D2 receptor antagonist, haloperidol (0.01- 0.1 mg/kg), and the mixed D2/D3 antagonists, amisulpiride (3.2-32 mg/kg) and sulpiride (32-200 mg/kg), failed to produce stimulus generalization, while the D3-preferring antagonists, (-)-DS121 (1-10 mg/kg) and (+)-AJ76 (3.2-32 mg/kg), produced complete stimulus generalization. Direct and indirect DA agonists, including apomorphine (0.01-0.32 mg/kg) and d-amphetamine (0.1-1 mg/kg), the D1 agonist SKF38393 (10-100 mg/kg), the D2 selective agonist PNU-95666E (0.32-3.2 mg/kg) and the D3-preferring agonist pramipexole (0.032-1 mg/kg), all produced non-significant amounts of drug-appropriate responding and significantly reduced response rate. It is concluded that PNU-99194A produces a distinctive subjective cue which is probably based on D3 receptor antagonism.
最近有文献记载,相对选择性的多巴胺D3受体拮抗剂PNU-99194A能够在大鼠中建立辨别性刺激控制,且与该化合物相关的辨别性线索与精神兴奋剂产生的线索不同。本实验通过在23只雄性Sprague-Dawley大鼠中检测其他几种多巴胺能药物的刺激泛化情况,进一步表征了PNU-99194A的辨别性刺激特性。这些大鼠在食物强化的FR10程序下的双选辨别程序中接受训练,以区分10mg/kg PNU-99194A(皮下注射,15分钟)和溶媒。大鼠在中位数为35.5次训练(范围23 - 78次)后达到连续十次训练正确选择杠杆的标准。在替代试验中,非选择性D2受体拮抗剂氟哌啶醇(0.01 - 0.1mg/kg)、D2/D3混合拮抗剂氨磺必利(3.2 - 32mg/kg)和舒必利(32 - 200mg/kg)未能产生刺激泛化,而偏向D3的拮抗剂(-)-DS121(1 - 10mg/kg)和(+)-AJ76(3.2 - 32mg/kg)产生了完全的刺激泛化。直接和间接的DA激动剂,包括阿扑吗啡(0.01 - 0.32mg/kg)和d-苯丙胺(0.1 - 1mg/kg)、D1激动剂SKF38393(10 - 100mg/kg)、D2选择性激动剂PNU-95666E(0.32 - 3.2mg/kg)和偏向D3的激动剂普拉克索(0.032 - 1mg/kg),均产生了非显著量的药物适应性反应,并显著降低了反应率。结论是,PNU-99194A产生了一种独特的主观线索,这可能基于D3受体拮抗作用。